A bill to lower the price of insulin drugs and supplies for more North Dakotans attracted passionate discussion at a Thursday ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for more North Dakotans.
North Dakota lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for ...
In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...
Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.
If innovative cancer therapies were the top launches to watch in 2024, this year’s high-profile biopharma debuts is slated to ...
Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The ...
Antiobesity drugs are amazing people by how fast they melt off pounds. But it's no surprise to Richard DiMarchi.
The "Semaglutides Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This Semaglutides market report covers market characteristics, size and growth, segmentation, regional ...
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
The European Commission has granted marketing authorisation for Novo Nordisk’s adult ... in a soluble formulation with insulin aspart. Both of these products will be available in Europe in ...